Mohamed Wa'el Ahmed Hashad
Chief Executive Officer at Longeveron Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2024
5 years of board service in total across 2 boards, counting each seat separately. Longest: Akari Therapeutics plc, 2 years.
Akari Therapeutics plc
Director
Longeveron Inc.
Director · Chief Executive Officer
Chief executive roles
Longeveron Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 15, 2025 | Longeveron Inc. | Grant or award | +180,000 | — | — |
| Jul 1, 2025 | Longeveron Inc. | Shares withheld for tax | −13,146 | $1.28 | $16,827 |
| Apr 1, 2025 | Longeveron Inc. | Shares withheld for tax | −13,384 | $1.50 | $20,076 |
| Jan 2, 2025 | Longeveron Inc. | Shares withheld for tax | −10,827 | $1.79 | $19,380 |
| Oct 1, 2024 | Longeveron Inc. | Shares withheld for tax | −13,357 | $1.88 | $25,111 |
| Aug 15, 2024 | Longeveron Inc. | Grant or award | +311,250 | — | — |
| Aug 15, 2024 | Longeveron Inc. | Shares withheld for tax | −39,248 | $2.46 | $96,550 |
| Apr 11, 2024 | Longeveron Inc. | Open-market purchase | +10,638 | $2.35 | $24,999 |
| Mar 12, 2024 | Longeveron Inc. | Grant or award | +80,200 | — | — |
| Mar 12, 2024 | Longeveron Inc. | Shares withheld for tax | −32,866 | $0.54 | $17,748 |
| Jan 2, 2024 | Longeveron Inc. | Shares withheld for tax | −5,123 | $1.32 | $6,762 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.